QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:ZURA

Zura Bio (ZURA) Stock Forecast, Price & News

$6.60
-0.23 (-3.37%)
(As of 09/26/2023 ET)
Compare
Today's Range
$6.58
▼
$7.02
50-Day Range
$5.75
▼
$7.03
52-Week Range
$4.87
▼
$37.55
Volume
123,761 shs
Average Volume
374,812 shs
Market Capitalization
$284.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.25
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Zura Bio MarketRank™ Forecast

Analyst Rating
Buy
3.25 Rating Score
Upside/​Downside
176.5% Upside
$18.25 Price Target
Short Interest
Healthy
0.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Zura Bio in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.27) to ($0.87) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

466th out of 964 stocks

Biological Products, Except Diagnostic Industry

69th out of 158 stocks

See Top Rated MarketRank™ Stocks Here

ZURA stock logo

About Zura Bio (NASDAQ:ZURA) Stock

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

ZURA Price History

ZURA Stock News Headlines

September 26, 2023 | americanbankingnews.com
Zura Bio (NASDAQ:ZURA) Trading Up 6.7%
September 12, 2023 | finance.yahoo.com
Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute
September 26, 2023 | Micro-Cap Stock Trader (Ad)
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 7, 2023 | barrons.com
Zura Bio Ltd. Wt
September 7, 2023 | finance.yahoo.com
We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely
August 25, 2023 | msn.com
Oppenheimer starts Zura Bio at outperform, cites potential of ZB-106
August 25, 2023 | msn.com
Oppenheimer Initiates Coverage of Zura Bio Ltd - (ZURA) with Outperform Recommendation
August 15, 2023 | msn.com
Raymond James Maintains Zura Bio Ltd - (ZURA) Strong Buy Recommendation
September 26, 2023 | Micro-Cap Stock Trader (Ad)
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
August 15, 2023 | markets.businessinsider.com
Where Zura Bio Stands With Analysts
August 14, 2023 | finance.yahoo.com
Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights
July 20, 2023 | seekingalpha.com
ZURAW Zura Bio Limited WT EXP 032028
June 23, 2023 | benzinga.com
Zura Bio shares are trading lower Wednesday amid possible profit-taking after the stock rallied on Tuesday.
June 23, 2023 | seekingalpha.com
Zura Bio to join Russell 2000 and Russell 3000 indexes
June 23, 2023 | benzinga.com
Zura Bio shares are trading higher after the company announced it will join the Russell 2000 and Russell 3000 indexes.
June 22, 2023 | seekingalpha.com
Zura Bio a new buy at Guggenheim on immunology, inflammation assets
June 22, 2023 | investing.com
Zura Bio Ltd (94E)
June 21, 2023 | fool.com
Zura Bio (NASDAQ: ZURA)
June 21, 2023 | markets.businessinsider.com
What's Going On With Zura Bio Stock Today
June 20, 2023 | fool.com
Why Shares of Zura Bio Climbed Tuesday
June 14, 2023 | benzinga.com
Chardan Capital Initiates Coverage On Zura Bio with Buy Rating, Announces Price Target of $14
June 6, 2023 | investorplace.com
Why Is Zura Bio (ZURA) Stock Up 9% Today?
June 6, 2023 | msn.com
GitLab, Hello Group, Sprinklr, And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
June 6, 2023 | marketwatch.com
Zura Shares Jump After $80 Million Private Placement Closes
June 6, 2023 | finance.yahoo.com
Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist
June 6, 2023 | msn.com
Zura Bio climbs 7% as director buys stock
May 24, 2023 | benzinga.com
Zura Bio shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy rating and a $20 price target.
See More Headlines
Receive ZURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zura Bio and its competitors with MarketBeat's FREE daily newsletter.

ZURA Company Calendar

Last Earnings
8/14/2023
Today
9/26/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZURA
CUSIP
N/A
CIK
1855644
Web
N/A
Phone
858-247-0520
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.25
High Stock Price Forecast
$22.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+172.4%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.55 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-110.19%
Return on Assets
-28.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.68
Quick Ratio
5.68

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$1.08 per share
Price / Cash Flow
6.22
Book Value
($2.21) per share
Price / Book
-3.03

Miscellaneous

Outstanding Shares
43,090,000
Free Float
36,285,000
Market Cap
$288.70 million
Optionable
Not Optionable
Beta
0.45
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. David Brady
    Head of Bus. Devel.
  • Dr. Someit Sidhu M.D. (Age 34)
    CEO & Director
  • Mr. Verender S. Badial (Age 51)
    Chief Financial Officer
  • Dr. Gary Whale (Age 49)
    Chief Technology Officer
  • Dr. Michael D. Howell Ph.D. (Age 46)
    Chief Scientific Officer & Head of Translational Science
  • Ms. Kimberly Ann Davis (Age 55)
    Chief Legal Officer & Sec.
  • Ms. Theresa Lowry (Age 49)
    Chief HR Officer
  • Dr. Christopher H. Cabell FACC (Age 54)
    M.D., MHS, Chief Medical Officer, Exec. VP and Head of R&D

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ZURA Stock - Frequently Asked Questions

Should I buy or sell Zura Bio stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zura Bio in the last twelve months. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ZURA shares.
View ZURA analyst ratings or view top-rated stocks.

What is Zura Bio's stock price forecast for 2023?

4 Wall Street research analysts have issued 12 month price objectives for Zura Bio's shares. Their ZURA share price forecasts range from $14.00 to $22.00. On average, they anticipate the company's share price to reach $18.25 in the next year. This suggests a possible upside of 172.4% from the stock's current price.
View analysts price targets for ZURA or view top-rated stocks among Wall Street analysts.

How have ZURA shares performed in 2023?

Zura Bio's stock was trading at $29.42 at the beginning of 2023. Since then, ZURA shares have decreased by 77.2% and is now trading at $6.70.
View the best growth stocks for 2023 here.

When is Zura Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our ZURA earnings forecast.

How were Zura Bio's earnings last quarter?

Zura Bio Limited (NASDAQ:ZURA) released its quarterly earnings results on Monday, August, 14th. The company reported ($1.31) earnings per share for the quarter, missing analysts' consensus estimates of ($0.25) by $1.06.

What is Zura Bio's stock symbol?

Zura Bio trades on the NASDAQ under the ticker symbol "ZURA."

Who are Zura Bio's major shareholders?

Zura Bio's stock is owned by a number of institutional and retail investors. Top institutional investors include Great Point Partners LLC (12.18%), Suvretta Capital Management LLC (10.54%), Deep Track Capital LP (5.86%), Citadel Advisors LLC (2.64%), Point72 Asset Management L.P. (1.73%) and BlackRock Inc. (1.50%).
View institutional ownership trends.

How do I buy shares of Zura Bio?

Shares of ZURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zura Bio's stock price today?

One share of ZURA stock can currently be purchased for approximately $6.70.

How much money does Zura Bio make?

Zura Bio (NASDAQ:ZURA) has a market capitalization of $288.70 million.

How can I contact Zura Bio?

Zura Bio's mailing address is C/O Maples Corporate Services Limited, Po Box 309 Ugland House, Grand Cayman KY1-11. The company can be reached via phone at 858-247-0520 or via email at annemarie.fields@sternir.com.

This page (NASDAQ:ZURA) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -